AAIC 2025 Abstract
Differential effects of sex on amyloid lowering by Aducanumab and IgG in 5xFAD mice
By Kathryn A. Haynes, Z. Cope, Sean-Paul Gerard Williams, Show 15 more authorsStacey J. Sukoff Rizzo
Experiments in animalsInterventions
Abstract
Background: While there is ongoing support to position amyloid‐targeting antibody‐based therapeutics as standard‐of‐care treatments for Alzheimer’s disease (AD), their benefits and limitations are debated.
